Past Webinar – Technology Use in Alzheimer’s Disease Research: Current Status & Future Promise, Rhoda Au
https://youtu.be/sXAMmZZ5YEM?si=d5QDssWNCXVmchEP Abstract: Digital technologies offer unprecedented opportunities to revolutionize cognitive health monitoring and Alzheimer’s disease prevention. Current high-burden, clinic-based assessments can be augmented by passive engagement technologies—leveraging smartphones and their array of embedded sensors for continuous, unobtrusive data collection. At the Framingham Heart Study and BU Alzheimer’s Disease Research Center, multi-sensor approaches combining smartphone applications, digital voice, eye-tracking, and in-home monitoring are being deployed to detect subtle cognitive and behavioral changes. Through the Davos Alzheimer’s Collaborative, a global minimal viable protocol has been launched, integrating digital and blood-based biomarkers across diverse populations. Data sharing via the Alzheimer’s Disease Data Initiative (ADDI) is accelerating discovery through open challenges and collaborative analytics. This paradigm shift emphasizes inclusivity, rethinking traditional study designs, and advancing from digital phenotyping to truly dynamic, multi-dimensional digital biomarkers. The long-term goal is early…